Biopankin julkaisut 2023

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas
Vesterinen, T.; Peltola, E.; Leijon, H.; Hannula, P.; Huhtala, H.; Mäkinen, M.J.; Nieminen, L.; Pirinen, E.; Rönty, M.; Söderström, M.; et al. Int. J. Mol. Sci. 2023, 24, 15164.

TWINGEN – protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer’s disease
Vuoksimaa, Saari et al. 2023

Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) – low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer
Pakkanen, P., Ilmarinen, T., Halme, E. et al. Virchows Arch (2023).

Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection
Víctor Urbiola-Salvador, Suiane Lima de Souza, Peter Grešner, Talha Qureshi and Zhi Chen. Int. J. Mol. Sci. 2023, 24(7), 6276

FinnGen provides genetic insights from a well-phenotyped isolated population
Kurki MI et al., Nature. 2023 Jan;613(7944):508-518. doi: 10.1038/s41586-022-05473-8. Epub 2023 Jan 18. PMID: 36653562

The validity of rheumatoid arthritis diagnoses in Finnish biobanks
J Paltta, H-K Heikkilä, L Pirilä, KK Eklund, J Huhtakangas, P Isomäki, O Kaipiainen-Seppänen, K Kristiansson, AS Havulinna, T Sokka-Isler, A Palomäki & for the FinnGen investigators (2023). Scandinavian Journal of Rheumatology, 52:1, 1-9, DOI: 10.1080/03009742.2021.1967047